]>
IRCT20221210056768N1 IRCT 2022-12-14 Iran University of Medical Sciences Silver containing dressing in wound management. Assessment of the effectiveness of hydrocolloid, silver containing dressing in the treatment of partial thickness skin graft donor sites. 2023-01-21 anticipated 42 Complete https://irct.ir/trial/67316 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is done in a simple way. Patients who meet the inclusion criteria will receive one of two different types of dressings. Of course, only the researcher will know the type of dressing used and the randomization sequence. Patients, nurses who provide care services, evaluators, and ultimately data analysts will not be aware of these things, Blinding description: The patient does not know the type of dressing used on the wound. The nurse who performs the service of changing the external layers of the dressing is not aware of the type of the main dressing used in the lower layer. The evaluator of the results who checks the results after removing the dressing does not know what type of dressing was used in each person. The data analyst does not know who the control group and the control group are. N/A Condition 1: final scar. Condition 2: Reepithelialization rate. Intervention group: Using the hydrocolloid, silver containing dressing in the treatment of split-thickness skin graft donor site. Yes - There is a plan to make this available What will be shared: The results of the variables for each individual will be published, as well as the demographic information of each individual. All findings and documents, except identity information, can be published. When: The findings will be available three months after the publication of the results. To whom: All academic researchers, and commercial users and employers in the field of wound healing products can use this data. Conditions: The use of data and results is unimpeded under any circumstances, citing the source. Where to obtain: I, Dr. Amir Ali Mirfakhrai, as the main person in charge of the project, am ready to share the data. Applicants can send their application to the email address Dr.mirfakhrae@gmail.com. How to obtain: After sending the application to the mentioned email, the data will be sent to the applicant within 2 weeks. Comments:
public Amirali Mirfakhraee
No 78, Heidari Ave, Zargande
Tehran Iran (Islamic Republic of) ۱۲۳۴۵۶۷۸۹۰ +98 21 2249 3050 ahiakhanahmadi1385@gmail.com Iran University of Medical Sciences scientific Mohammadreza Akhoondi nasab
21 Alley, Yousefabad Ave.
Tehran Iran (Islamic Republic of) ۱۲۴۴۵۶۷۸۹۰ +98 21 2249 3050 ahiakhanahmadi1985@gmail.com Iran University of Medical Sciences Iran (Islamic Republic of) Patients who undergo split thickness skin graft Age above 18, and under 60 No interfering medical conditions Getting the informed consent 18 years 60 years Both Age under 18, or above 60 Reluctance of the patient Any significant morbidity such as uncontrolled diabetes L90.5 Scar conditions and fibrosis of skin Treatment - Devices Intervention group: Using the hydrocolloid, silver containing dressing in the treatment of split-thickness skin graft donor site The final scar of the wound - at the end of the first and sixth months, the quality of the scar and the scar score are evaluated based on the Vancouver scar measurement criteria, and the average scar score in the two groups is compared. Timepoint: After 1 month, and 6 months. Method of measurement: According to the Vancouver Scar Scale. Iran University of Medical Sciences Approved 2022-02-08 Ethics committee of Iran University of Medical Science Iran university of medical science, Hemmat Highway Tehran Tehran Iran (Islamic Republic of)